Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-09-13

FDA Approved: KATERZIA — Supplemental Application (Azurity Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for KATERZIA (amlodipine) from Azurity Pharmaceuticals, Inc., expanding the approved labeling/formulation under a supple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • KATERZIA (AMLODIPINE)

Snippet

SUPPL AP for KATERZIA (AMLODIPINE)